These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 30887551)

  • 1. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.
    Dąbrowska K
    Med Res Rev; 2019 Sep; 39(5):2000-2025. PubMed ID: 30887551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy.
    Podlacha M; Grabowski Ł; Kosznik-Kawśnicka K; Zdrojewska K; Stasiłojć M; Węgrzyn G; Węgrzyn A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages of the Urinary Microbiome.
    Miller-Ensminger T; Garretto A; Brenner J; Thomas-White K; Zambom A; Wolfe AJ; Putonti C
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29378882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages engineered to display foreign peptides may become short-circulating phages.
    Hodyra-Stefaniak K; Lahutta K; Majewska J; Kaźmierczak Z; Lecion D; Harhala M; Kęska W; Owczarek B; Jończyk-Matysiak E; Kłopot A; Miernikiewicz P; Kula D; Górski A; Dąbrowska K
    Microb Biotechnol; 2019 Jul; 12(4):730-741. PubMed ID: 31037835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.
    Nguyen S; Baker K; Padman BS; Patwa R; Dunstan RA; Weston TA; Schlosser K; Bailey B; Lithgow T; Lazarou M; Luque A; Rohwer F; Blumberg RS; Barr JJ
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages and the Immune System.
    Popescu M; Van Belleghem JD; Khosravi A; Bollyky PL
    Annu Rev Virol; 2021 Sep; 8(1):415-435. PubMed ID: 34014761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human Gut Phage Community and Its Implications for Health and Disease.
    Manrique P; Dills M; Young MJ
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28594392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model.
    Hsu BB; Gibson TE; Yeliseyev V; Liu Q; Lyon L; Bry L; Silver PA; Gerber GK
    Cell Host Microbe; 2019 Jun; 25(6):803-814.e5. PubMed ID: 31175044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy pharmacology.
    Abedon ST; Thomas-Abedon C
    Curr Pharm Biotechnol; 2010 Jan; 11(1):28-47. PubMed ID: 20214606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Pharmacokinetics of Suppository Forms of Bacteriophages.
    Bochkareva SS; Karaulov AV; Aleshkin AV; Novikova LI; Kiseleva IA; Rubal'skii EO; Mekhtiev ER; Styshnev AO; Zul'karneev ER; Anurova MN; Bakhrushina EO; Letarov AV
    Bull Exp Biol Med; 2020 Apr; 168(6):748-752. PubMed ID: 32328936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A theoretical model of temperate phages as mediators of gut microbiome dysbiosis.
    Lin DM; Lin HC
    F1000Res; 2019; 8():. PubMed ID: 31316751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Co-occurrence Networks Reflect Bacteriophage Ecology and Evolution.
    Shapiro JW; Putonti C
    mBio; 2018 Mar; 9(2):. PubMed ID: 29559574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut.
    Castro-Mejía JL; Muhammed MK; Kot W; Neve H; Franz CM; Hansen LH; Vogensen FK; Nielsen DS
    Microbiome; 2015 Nov; 3():64. PubMed ID: 26577924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.